造血干细胞移植应作为高度活动性多发性硬化症的二线治疗方法——是。 - Suppr

Suppr

超能文献

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.

作者信息

Freedman Mark, Atkins Harold L

机构信息

University of Ottawa-Neuroscience, Ottawa, ON, Canada

Regenerative Medicine, Ottawa Hospital Research Institute-Medicine, Ottawa, ON, Canada.

出版信息

Mult Scler. 2016 Sep;22(10):1258-9. doi: 10.1177/1352458516654311. Epub 2016 Jul 21.

DOI:10.1177/1352458516654311

PMID:27444560

Abstract

摘要

相似文献

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.

Mult Scler. 2016 Sep;22(10):1258-9. doi: 10.1177/1352458516654311. Epub 2016 Jul 21.

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.

Mult Scler. 2016 Sep;22(10):1260-3. doi: 10.1177/1352458516644341. Epub 2016 Jul 21.

Autologous haematopoietic stem cell transplantation.

Neurol Sci. 2005 May;26 Suppl 1:S19. doi: 10.1007/s10072-005-0394-9.

Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS.

Neurology. 2015 Mar 10;84(10):968-9. doi: 10.1212/WNL.0000000000001347. Epub 2015 Feb 11.

Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.

J Neurol Sci. 2004 Aug 15;223(1):53-8. doi: 10.1016/j.jns.2004.04.020.

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary.

Mult Scler. 2016 Sep;22(10):1263-5. doi: 10.1177/1352458516660206. Epub 2016 Jul 21.

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought.

Neurology. 2017 May 30;88(22):2072-2073. doi: 10.1212/WNL.0000000000003995. Epub 2017 Apr 28.

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.

Hematology. 2016 Jan;21(1):42-5. doi: 10.1179/1607845415Y.0000000049. Epub 2015 Sep 2.

Autologous hematopoietic cell transplantation in multiple sclerosis.

Expert Opin Biol Ther. 2017 Jan;17(1):77-86. doi: 10.1080/14712598.2017.1239706. Epub 2016 Oct 14.

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.

Neurol Sci. 2005 Dec;26 Suppl 4:S200-3. doi: 10.1007/s10072-005-0514-6.

引用本文的文献

A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future.

Inflamm Res. 2019 Jan;68(1):25-38. doi: 10.1007/s00011-018-1185-0. Epub 2018 Sep 3.

Stem cells: Stemming the tide.

Nature. 2016 Nov 30;540(7631):S11-S12. doi: 10.1038/540S11a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.

Mult Scler. 2016 Sep;22(10):1258-9. doi: 10.1177/1352458516654311. Epub 2016 Jul 21.

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO.

Mult Scler. 2016 Sep;22(10):1260-3. doi: 10.1177/1352458516644341. Epub 2016 Jul 21.

Autologous haematopoietic stem cell transplantation.

Neurol Sci. 2005 May;26 Suppl 1:S19. doi: 10.1007/s10072-005-0394-9.

Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS.

Neurology. 2015 Mar 10;84(10):968-9. doi: 10.1212/WNL.0000000000001347. Epub 2015 Feb 11.

Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.

J Neurol Sci. 2004 Aug 15;223(1):53-8. doi: 10.1016/j.jns.2004.04.020.

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary.

Mult Scler. 2016 Sep;22(10):1263-5. doi: 10.1177/1352458516660206. Epub 2016 Jul 21.

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought.

Neurology. 2017 May 30;88(22):2072-2073. doi: 10.1212/WNL.0000000000003995. Epub 2017 Apr 28.

Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.

Hematology. 2016 Jan;21(1):42-5. doi: 10.1179/1607845415Y.0000000049. Epub 2015 Sep 2.

Autologous hematopoietic cell transplantation in multiple sclerosis.

Expert Opin Biol Ther. 2017 Jan;17(1):77-86. doi: 10.1080/14712598.2017.1239706. Epub 2016 Oct 14.

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.

Neurol Sci. 2005 Dec;26 Suppl 4:S200-3. doi: 10.1007/s10072-005-0514-6.

引用本文的文献

A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future.

Inflamm Res. 2019 Jan;68(1):25-38. doi: 10.1007/s00011-018-1185-0. Epub 2018 Sep 3.

Stem cells: Stemming the tide.

Nature. 2016 Nov 30;540(7631):S11-S12. doi: 10.1038/540S11a.